| Literature DB >> 31069127 |
Sarah E Rudasill1, Jonathan R Dattilo2, Jiabin Liu3, Atul F Kamath4.
Abstract
INTRODUCTION: Hip fractures in the elderly individuals are associated with significant morbidity and mortality, and outcomes are directly related to prompt surgical intervention with either total hip arthroplasty (THA) or hemiarthroplasty. Minority hip fracture patients have increased delays to surgical intervention and poorer functional outcomes. This study explored racial biases in the surgical treatment decision between THA and hemiarthroplasty for displaced femoral neck fractures as well as racial disparities in postoperative complications, readmission rates, and 30-day mortality.Entities:
Keywords: disparity; femoral neck fractures; fragility fractures; geriatric trauma; systems of care
Year: 2019 PMID: 31069127 PMCID: PMC6492349 DOI: 10.1177/2151459319841741
Source DB: PubMed Journal: Geriatr Orthop Surg Rehabil ISSN: 2151-4585
Distribution of Patients by Race and Procedure.
| Procedure | White, n = 7537 | Black, n = 346 | Hispanic, n = 405 | Asian, Native Hawaiian/Pacific Islander, American Indian/Alaska Native, n = 250 | Total, N = 8538 |
|---|---|---|---|---|---|
| Hemiarthroplasty, n = 7611 | 88.3% | 4.0% | 4.7% | 3.0% | 89.1% |
| Total hip arthroplasty, n = 927 | 88.2% | 4.3% | 4.9% | 2.6% | 10.9% |
| Total | 88.3% | 4.1% | 4.7% | 2.9% | 100% |
Predictive Factors for Total Hip Arthroplasty Versus Hemiarthroplasty.
| Predictive Factor | Odds Ratio | 95% Confidence Interval |
|
|---|---|---|---|
| Age | 0.730 | 0.625∼0.854 | <.001 |
| Female | 0.822 | 0.557∼1.214 | .324 |
| Race | |||
| Caucasian | Ref | Ref | Ref |
| Black | 0.716 | 0.319∼1.609 | .419 |
| Hispanic | 1.007 | 0.504∼2.012 | .985 |
| Asian, Native Hawaiian/Pacific Islander, American Indian | 0.390 | 0.049∼3.119 | .375 |
| Operation year | 0.963 | 0.853∼1.086 | .538 |
| Diabetes | |||
| Non-insulin dependent | 1.077 | 0.618∼1.879 | .792 |
| Insulin dependent | 1.099 | 0.521∼2.319 | .805 |
| Dyspnea | |||
| At rest | 0.825 | 0.444∼1.532 | .542 |
| Moderate exertion | 0.678 | 0.219∼2.098 | .500 |
| Functional status | |||
| Independent | Ref | Ref | Ref |
| Dependent | 0.941 | 0.706∼1.255 | .681 |
| Chronic obstructive pulmonary disease (COPD) | 0.711 | 0.386∼1.309 | .273 |
| Liver disease | 2.178 | 0.191∼24.84 | .531 |
| Congestive heart failure | 0.957 | 0.348∼2.627 | .931 |
| Coronary artery disease | 1.189 | 0.0.751∼1.883 | .460 |
| Hypertension | 1.593 | 1.038∼2.445 | .033 |
| Peripheral vascular disease | 0.135 | 0.018∼1.007 | .051 |
| Renal failure | 0.175 | 0.023∼1.341 | .093 |
| Central nervous system disorder | 0.925 | 0.597∼1.434 | .728 |
| Spinal cord injury | Omitted | ||
| Surgery within the last 30 days | 2.221 | 0.434∼11.36 | .338 |
| Steroid use for chronic condition | 1.937 | 1.056∼3.552 | .033 |
Complications and Mortality by Race.
| Outcome | White, n = 7537 | Black, n = 346 | Hispanic, n = 405 | Asian, Native Hawaiian/Pacific Islander, American Indian/Alaska Native, n = 250 |
|
|---|---|---|---|---|---|
| Infection | 1.4% | 1.9% | 1.7% | 2.0% | .209 |
| Cardiopulmonary complication | 1.0% | 1.2% | 0.9% | 1.1% | .863 |
| Any major complication | 5.2% | 5.3% | 4.6% | 6.7% | .013 |
| Mortality | 0.3% | 0.4% | 0.3% | 0.9% | .014 |
| Readmission | 4.2% | 4.7% | 3.9% | 4.3% | .588 |